PAPER Khedr EM, Ahmed MA, Darwish ES, Ali AM
SEARCH RESULTS
331008 RESULTS
PAPER Vellas B, Pesce A, Robert PH, Aisen PS, Ancoli-Israel S, Andrieu S, Cedarbaum J, Dubois B, Siemers E, Spire JP, Weiner MW, May TS
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials.
Alzheimers Dement. 2011 Jul;7(4):e109-17. PubMed: 21784343PAPER Antúnez C, Boada M, López-Arrieta J, Moreno-Rey C, Hernández I, Marín J, Gayán J, , González-Pérez A, Real LM, Alegret M, Tárraga L, Ramírez-Lorca R, Ruiz A
Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):e124-9. PubMed: 21784344PAPER Xie SX, Baek Y, Grossman M, Arnold SE, Karlawish J, Siderowf A, Hurtig H, Elman L, McCluskey L, Van Deerlin V, Lee VM, Trojanowski JQ
Building an integrated neurodegenerative disease database at an academic health center.
Alzheimers Dement. 2011 Jul;7(4):e84-93. PubMed: 21784346PAPER Schindler RJ, Carrillo MC
Output of the working group on magnetic resonance imaging abnormalities and treatment with amyloid-modifying agents.
Alzheimers Dement. 2011 Jul;7(4):365-6. PubMed: 21784347PAPER Carlson C, Estergard W, Oh J, Suhy J, Jack CR, Siemers E, Barakos J
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.
Alzheimers Dement. 2011 Jul;7(4):396-401. PubMed: 21784350PAPER Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Lladó A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O'Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schröder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
Alzheimers Dement. 2011 Jul;7(4):386-395.e6. PubMed: 21784349PAPER Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
Alzheimers Dement. 2011 Jul;7(4):456-65. PubMed: 21784354PAPER Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):474-485.e4. PubMed: 21784356PAPER Hornberger M, Geng J, Hodges JR
Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia.
Brain. 2011 Sep;134(Pt 9):2502-12. PubMed: 21785117PAPER Cornejo A, Jiménez JM, Caballero L, Melo F, Maccioni RB
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):143-53. PubMed: 21785188PAPER David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM,
Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.
J Alzheimers Dis. 2011 Jan 1;27(1):155-61. PubMed: 21785189PAPER Facecchia K, Fochesato LA, Ray SD, Stohs SJ, Pandey S
Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies.
J Toxicol. 2011;2011:683728. PubMed: 21785590PAPER Atkins ER, Panegyres PK
The clinical utility of gene testing for Alzheimer's disease.
Neurol Int. 2011 Jun;3(1):e1. PubMed: 21785673PAPER Shibata N, Ohnuma T, Kuerban B, Komatsu M, Baba H, Arai H
Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population.
Int J Alzheimers Dis. 2011;2011:762471. PubMed: 21785701Current Filters
No filters selected